Radiation therapy in colorectal carcinoma

Area of Science:

• Oncology
• Surgical Oncology
• Radiation Oncology

Background:

• Advanced rectal and colon carcinomas exhibit high local recurrence rates despite surgical improvements.
• Radiotherapy addition to colorectal carcinoma treatment has shown promise in reducing local recurrence.
• Combined modality treatment demonstrates tolerable toxicity and benefits for higher-stage patients.

Purpose of the Study:

• To evaluate the efficacy of adjuvant radiotherapy in reducing local recurrence for advanced colorectal carcinomas.
• To assess the toxicity and benefits of combined modality treatment in higher-stage colorectal cancer patients.
• To explore the potential of intraoperative radiotherapy for unresectable and recurrent lesions.

Main Methods:

• Review of treatment outcomes for colorectal carcinoma patients.
• Analysis of local recurrence rates with and without adjuvant radiotherapy.
• Assessment of acute and chronic toxicity associated with radiotherapy.
• Investigation into intraoperative radiotherapy for specific patient groups.

Main Results:

• Adjuvant radiotherapy significantly diminishes local recurrence rates in colorectal carcinoma.
• The acute and chronic toxicity associated with radiotherapy is generally tolerable.
• Patients with higher stages of colorectal carcinoma benefit from combined modality treatment.
• Intraoperative radiotherapy shows promise for unresectable and recurrent lesions.

Conclusions:

• Adjuvant radiotherapy is recommended for modified Astler-Coller stages B2 or greater in colorectal carcinoma.
• Combined modality treatment offers benefits for advanced colorectal cancer stages with manageable toxicity.
• Further research is needed to determine optimal sequencing with chemotherapy and the full potential of intraoperative radiotherapy.